HMOX1 activators(Heme oxygenase 1 activators), NLRP3 agonists(NACHT, LRR and PYD domains-containing protein 3 agonists), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants)

Therapeutic Areas

NeoplasmsImmune System DiseasesSkin and Musculoskeletal Diseases+ [1]

Active Indication

OsteoarthritisProstatic CancerRheumatoid Arthritis

Inactive Indication-

Originator Organization-

Active Organization

Yantai Yuhuangding Hospital

Wenzhou Medical CollegeChina Center for Pharmaceutical International Exchange (CCPIE)

Inactive Organization-

License Organization-

Drug Highest PhasePreclinical

First Approval Date-

Regulation-

Structure/Sequence

Molecular FormulaC19H16O4

InChIKeyPREBVFJICNPEKM-YDWXAUTNSA-N

CAS Registry33171-05-0

100 Clinical Results associated with Bisdemethoxycurcumin

100 Translational Medicine associated with Bisdemethoxycurcumin

100 Patents (Medical) associated with Bisdemethoxycurcumin

1,777

Literatures (Medical) associated with Bisdemethoxycurcumin

01 May 2025·International Journal of Biological Macromolecules

Combining porous starch and polyoxyethylene hydrogenated castor oil RH40 to enhance the solubility, stability, and bioavailability of bisdemethoxycurcumin

Article

Author: Ma, Zhongyi ; Du, Yan ; Duan, Xuehui ; Liang, Xuewei ; Tang, Yixuan ; Yang, Andong ; Tang, Zhongjie ; Zhu, Ning

Bisdemethoxycurcumin (BDC) is an important ingredient derived from the food spice turmeric. Although BDC exhibits various pharmacological effects, it is characterized by poor water solubility and limited stability under light. Considering that the high specific surface area of porous starch (PS) renders it an ideal carrier for the encapsulation of active compounds, and polyoxyethylene‑hydrogenated castor oil RH40 (RH40) is an effective solubilizer for BDC, the current study optimized the PS/RH40/BDC formulation to combine these advantages. Consequently, a PS/RH40/BDC ratio of 10:3:1 was identified as optimal (RH-PS/BDC). Characterization using scanning electron microscopy, X-ray diffractometry, Fourier-transform infrared spectroscopy, Brunauer-Emmett-Teller analysis, and stability testing indicated that BDC was amorphously encapsulated within the RH-PS system, thereby leading to enhanced stability and solubility. Furthermore, cellular uptake experiments revealed a significant increase of RH-PS/BDC. In terms of the enhancement mechanism, RH40 can reduce cell membrane fluidity and open tight junctions between intestinal epithelial cells, thereby facilitating BDC absorption. In vivo pharmacodynamic analysis confirmed that RH-PS/BDC effectively inhibited LPS-induced cerebral neuritis. Overall, this study demonstrates the role of PS in combination with RH40 in enhancing the stability and bioavailability of BDC. This simple and efficient preparation strategy is promising for future research and product development.

01 May 2025·Food Hydrocolloids

Investigating curcuminoid encapsulation in β-cyclodextrin: Insights from NMR spectroscopy and MD simulations

Author: Ansari, Suleman Jalilahmad ; Chaudhari, Sachin R. ; Mogurampelly, Santosh ; Biswas, Anisha ; Dandamudi, Usharani ; Naresh, K. S.

Curcuminoids, key bioactive compounds in turmeric, exhibit significant health benefits but suffer from poor bioavailability, limiting their therapeutic potential.Cyclodextrin (CD) encapsulation is a promising strategy to enhance bioavailability, yet studies primarily focus on curcumin (CUR), with limited exploration of other major curcuminoids such as demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC).This study provides a comprehensive comparative anal. of the encapsulation behavior of CUR, DMC, and BDMC within β-cyclodextrin (β-CD) using a combination of phase solubility anal., NMR spectroscopy (1D-¹H NMR, 2D-NOESY and DOSY), and mol. dynamics (MD) simulations. ¹H NMR, NOESY spectra and diffusion studies revealed the strongest inclusion complex formation for BDMC, confirmed by phase stability constants (K).Mol. dynamics simulations further quantified the interaction strength through radial distribution functions (RDFs), close contact analyses, and hydrogen bonding patterns, highlighting the absence of -OCH₃ groups in BDMC as a key factor for enhanced interaction.These findings provide crucial mechanistic insights into curcuminoids encapsulation, suggesting BDMC as a superior candidate for β-CD formulations, with implications for developing more effective nutraceutical and drug delivery systems.

01 May 2025·Food Chemistry

Unleashing the nutritional potential of Brassica microgreens: A case study on seed priming with Vermicompost

Article

Author: Capri, Ettore ; Zengin, Gokhan ; García-Pérez, Pascual ; Lucini, Luigi ; De Gregorio, Marco A

Microgreens constitute ready-to-eat functional foods, being rich sources of phytonutrients and phytochemicals. Because of their short life cycle, seed priming is a promising strategy to fortify their functional outcome. Vermicompost was applied as seed priming agent for four Brassicaceae microgreens of nutritional interest. The combination of untargeted metabolomics and in vitro assays highlighted the involvement of phenolics and glucosinolates in the functional traits of microgreens, following species-specific responses. Cress accumulated specific polyphenols at low vermicompost dosage, while daikon mainly accumulated aliphatic glucosinolates. Mustard and red cabbage were found to repress glucosinolate accumulation while eliciting polyphenols following vermicompost fortification. The application of machine learning chemometrics revealed that both families of compounds coordinated the functionality of microgreens in terms of antioxidant and neuroprotective bioactivities, highlighting the importance of optimizing genotype-specific interventions. This research sheds light on nutritional enhancement of functional foods, paving the way toward the establishment of novel sustainable food systems.

100 Deals associated with Bisdemethoxycurcumin

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Osteoarthritis	Preclinical	China	Wenzhou Medical College	27 Feb 2024
Prostatic Cancer	Preclinical	China	China Center for Pharmaceutical International Exchange (CCPIE)	01 Jan 2024
Rheumatoid Arthritis	Preclinical	China	Yantai Yuhuangding Hospital	01 Jan 2024

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Bisdemethoxycurcumin

Overview

Basic Info

Structure/Sequence

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation